Literature DB >> 12911938

Total registration of non-Hodgkin's lymphoma and Hodgkin's disease in Scotland: effect of deprivation and caseload on outcome.

J C Ewing1, J M White, A Rattray, A Lessells, M J Mackie.   

Abstract

All cases S16 years of age with a histological diagnosis of non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD) presented in Scotland between 1 January 1994 and 31 December 1996 were registered prospectively in the Scotland and Newcastle Lymphoma Group database by a process of total registration. The census population of Scotland in 1996-1997 was 5.1 million. One thousand seven hundred and sixty three patients were registered with NHL and 350 patients with HD. These patients have been followed up for a median of 47 months in the case of NHL and 51 months for HD cases. Actuarial 5-year survival for adult NHL was 35% and for HD, 75%. Outcome for both NHL and HD was particularly poor in the population over 60 years with median survival of 18 months for NHL and 27 months for HD. When analysis of survival was related to degree of material deprivation using the Carstairs score a significantly poorer survival was seen for NHL with increasing deprivation that could not be explained by a different pattern of age or stage at presentation. Deprivation had no impact on incidence or survival in HD. Analysis of impact of caseload of the physician initiating therapy showed no significant difference in 5-year survival.

Entities:  

Mesh:

Year:  2003        PMID: 12911938     DOI: 10.1080/1024533031000135685

Source DB:  PubMed          Journal:  Hematology        ISSN: 1024-5332            Impact factor:   2.269


  5 in total

Review 1.  State-of-the-art issues in Hodgkin's lymphoma survivorship.

Authors:  Shrujal S Baxi; Matthew J Matasar
Journal:  Curr Oncol Rep       Date:  2010-11       Impact factor: 5.075

2.  Analyzing the effect of physician assignment in the survival of patients with advanced non-small-cell lung cancer.

Authors:  P Wheatley-Price; H Jonker; K Al-Baimani; T Mhang; G Nicholas; G Goss; S A Laurie
Journal:  Curr Oncol       Date:  2020-02-01       Impact factor: 3.677

3.  Socioeconomic position, treatment, and survival of non-Hodgkin lymphoma in Denmark--a nationwide study.

Authors:  B L Frederiksen; S O Dalton; M Osler; M Steding-Jessen; P de Nully Brown
Journal:  Br J Cancer       Date:  2012-02-07       Impact factor: 7.640

4.  Affluence and Private Health Insurance Influence Treatment and Survival in Non-Hodgkin's Lymphoma.

Authors:  Harry Comber; Marianna De Camargo Cancela; Trutz Haase; Howard Johnson; Linda Sharp; Jonathan Pratschke
Journal:  PLoS One       Date:  2016-12-19       Impact factor: 3.240

5.  Overview of lymphoma diagnosis in Brazilian public health system patients: Open data analysis for health care planning.

Authors:  Denise Pires Martins; Nelson Francisco Correa-Netto; Nina Melo; Sandra Regina Loggetto; Marcia Mello Costa de Liberal
Journal:  Hematol Transfus Cell Ther       Date:  2020-11-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.